CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern ...
RICHMOND, Va. -- The Alliance for Building Better Medicine, which is comprised of more than 20 companies, colleges, and nonprofits in Richmond and Petersburg, has been designated as a technology and ...
Liquid AI and Insilico Medicine today announced a partnership that creates lightweight scientific foundation models for ...
AI in pharmaceuticals is set to transform drug discovery, clinical trials, manufacturing, and marketing by analysing vast datasets to speed up processes, reduce costs, and enable personalised medicine ...
In today’s Pharmaceutical Executive Daily, the FDA issues a Complete Response Letter for Disc Medicine’s bitopertin in EPP, Edwards Lifesciences lifts its anti-copycat policy, and industry leaders ...
In today’s ever-changing market place, pharmaceutical companies are challenged to reach, engage and persuade physicians in new, more effective ways. With changing behavioral influences, rising ...
leveraging Insilico’s proprietary Pharma.AI platform to jointly develop small molecule inhibitors, focusing on specific targets for cardiometabolic disease management. Jan 27, 2026 -- Insilico ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results